In our study, its antiarrhythmic effect seems to be specific to TANGO2-deficient cells; however, it may have broader implications in other arrhythmias associated with genes commonly implicated in energy or metabolic processes, such as TECRL (38), EXOSC5 (39), and C1QBP (40). The gene discussed is TECRL; the disease is Arrhythmia.